RNA
Income statement / Annual
Last year (2025), Avidity Biosciences Inc's total revenue was $18.62 M,
and the percentage change from the previous year is not available.
In 2025, Avidity Biosciences Inc's net income was -$76.68 M.
See Avidity Biosciences Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
| Period Ended |
12/31/2025 |
| Operating Revenue |
$18.62 M |
| Cost of Revenue |
$0.00
|
| Gross Profit |
$18.62 M
|
| Gross Profit Ratio |
1
|
| Research and Development Expenses |
$53.76 M
|
| General & Administrative Expenses |
$41.68 M
|
| Selling & Marketing Expenses |
$0.00
|
| Selling, General & Administrative Expenses |
$41.68 M
|
| Other Expenses |
$0.00
|
| Operating Expenses |
$95.43 M
|
| Cost And Expenses |
$95.43 M
|
| Interest Income |
$0.00
|
| Interest Expense |
$0.00
|
| Depreciation & Amortization |
$323.00 K
|
| EBITDA |
-$76.50 M |
| EBITDA Ratio |
-4.11
|
| Operating Income Ratio |
-4.13
|
| Total Other Income/Expenses Net |
-$12.00 K
|
| Income Before Tax |
-$76.83 M
|
| Income Before Tax Ratio |
-4.13
|
| Income Tax Expense |
-$142.00 K
|
| Net Income |
-$76.68 M
|
| Net Income Ratio |
-4.12
|
| EPS |
-4.48 |
| EPS Diluted |
-4.48 |
| Weighted Average Shares Out |
$17.11 M
|
| Weighted Average Shares Out Diluted |
$17.11 M
|
| Link |
|
